Endeavor BioMedicines

22/04/2025

From fresh air to vibrant communities, our environment shapes the lives we lead and the health we strive for. Today, let's appreciate the world around us—and our shared commitment to healthier futures for all.

02/04/2025

We’re pleased to welcome Lisa Lancaster, M.D., as Chief Medical Officer. She is a renowned pulmonologist and clinical researcher with extensive expertise in interstitial lung disease (ILD). In this role, Dr. Lancaster will guide the advancement of our clinical development programs.
Learn more: https://bit.ly/4iPQGLc

27/11/2024

We are proud of each person on and thankful for their contributions toward our mission of disrupting disease and restoring hope. is something we celebrate often at Endeavor, but at this time of year we take extra time to focus on what is grateful for. Listen to what the team said.

!

18/11/2024

This , we are sending gratitude and appreciation to caregivers of people with idiopathic (IPF). Being a caregiver can be a rewarding and challenging role, and the support you provide is essential. Check out the Pulmonary Fibrosis Foundation’s website for great resources: https://bit.ly/3YtTdlx

01/11/2024

We hope you had a happy 🎃! We celebrated with a day filled with creativity, fun, and .

01/10/2024

Today we had the honor of hosting PF Warriors’ Teresa Barnes, Chief Executive Warrior, Dolly Kervitsky, President, and MaryLuz Fuentes, MD, Director, Spanish Language Program, who shared their experience with during our company-wide event to honor . PF Warriors - Pulmonary Fibrosis, IPF, other Rare Lung Diseases' mission to help people facing these life-altering lung conditions to live their best possible lives after diagnosis inspires us in our own mission to make a meaningful difference in patients’ lives. Learn more about PF Warriors’ impactful work to help patients: https://bit.ly/3ZjJPCQ

26/09/2024

At Endeavor BioMedicines, we are developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases. Here is part of the outstanding team that is committed to restoring hope for patients and progressing our lead investigational candidate ENV-101 for the treatment of idiopathic pulmonary fibrosis. (IPF).

24/09/2024

that when someone is living with , thickened scar tissue builds on the tiny air sacs in their lungs? This can make breathing difficult, cause shortness of breath and trigger coughing.

This , learn more about pulmonary fibrosis through Pulmonary Fibrosis Foundation’s 30 facts in 30 days campaign: https://bit.ly/3ZmN4d2

At Endeavor BioMedicines, we aim to change treatment expectations and restore hope for individuals with pulmonary fibrosis.

13/09/2024

: It’s Pulmonary Fibrosis Awareness Month ( ) and Endeavor Biomedicines’ CEO John Hood, PhD, shares his point of view on the urgency of delivering more effective treatments for people with idiopathic pulmonary fibrosis ( ). Read more here:

In September 2022, journalist and critic Robert Woodward published a compelling editorial decrying both the lack of awareness and lack of effective treatments for idiopathic pulmonary fibrosis (IPF), a disease he’d never heard of before his own diagnosis. Less than a year later, Woodward became an...

09/09/2024

This month, we are joining the Pulmonary Fibrosis Foundation in raising awareness and supporting their mission to accelerate the development of new treatments. Join us and learn how you can help at pulmonaryfibrosis.org.